Ultragenyx (RARE) stock is down 40% since March 2024 amid ongoing financial struggles. See more insights on its growth ...
Zacks Investment Research on MSN
FDA Extends Review of DNLI's Hunter Syndrome Drug by Three Months
Denali Therapeutics Inc. DNLI announced that the FDA has extended its review timeline of the Biologics License Application ...
The disease gradually takes away the skills children have learned—leading to seizures, movement difficulties and profound ...
The microcap biotech stock had its best day ever after the FDA granted its rare-disease drug a breakthrough designation.
Breakthrough Therapy Designation Supported by Integrated Long-Term Clinical Data Demonstrating Normalization in Cerebral Spinal Fluid Heparan Sulfate Non-Reducing End (CSF HS-NRE) U.S. FDA Confirmed ...
KNOXVILLE, Tenn. — Bryan and Blair Begbie said all they want for Rowan — their youngest daughter — is the chance to be a kid. However, the Food and Drug Administration issued what is called a Complete ...
In December of 2022, Linda Zoslocki, a then-69-year-old retired high school counselor in Modesto, California, had a deep cough that wouldn’t go away. She was tired, and her legs had been swollen for ...
Spruce Biosciences, Inc. (OTCQB: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, ...
Dublin, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The "Mucopolysaccharidosis III (Sanfilippo Syndrome):Market View" report has been added to ResearchAndMarkets.com's offering. This reports provides a ...
NOVATO, Calif., July 11, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (RARE), today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) ...
Social media creators have been known to use AI filters to make their waists look smaller or their breasts appear bigger, but now disturbing Instagram and TikTok accounts are stooping to a far more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results